TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,763 | +13.7% | 19,054 | +13.4% | 0.00% | +50.0% |
| Q2 2023 | $259,338 | +156127.7% | 16,800 | +58.1% | 0.00% | – |
| Q4 2022 | $166 | -99.9% | 10,629 | +0.4% | 0.00% | -100.0% |
| Q3 2022 | $137,000 | -94.3% | 10,588 | -93.8% | 0.00% | -90.5% |
| Q2 2022 | $2,388,000 | +23.9% | 170,067 | +26.3% | 0.02% | +40.0% |
| Q1 2022 | $1,928,000 | +53.3% | 134,682 | +46.0% | 0.02% | +66.7% |
| Q4 2021 | $1,258,000 | -36.4% | 92,243 | -23.7% | 0.01% | -30.8% |
| Q3 2021 | $1,979,000 | +156.3% | 120,847 | +163.4% | 0.01% | +85.7% |
| Q2 2021 | $772,000 | +23.9% | 45,874 | +34.4% | 0.01% | +16.7% |
| Q1 2021 | $623,000 | +52.0% | 34,129 | +51.3% | 0.01% | +50.0% |
| Q4 2020 | $410,000 | +376.7% | 22,553 | +370.8% | 0.00% | +300.0% |
| Q2 2020 | $86,000 | – | 4,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |